.jpg)
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes
This network meta-analysis assesses whether age or sex are associated with differences in the efficacy of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase 4 inhibitors in adults with type 2 diabetes.
This network meta-analysis assesses whether age or sex are associated with differences in the efficacy of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase 4 inhibitors in adults with type 2 diabetes.
